Stockreport

EMA’s Paediatric Committee Agrees to Albireo’s A4250 Pediatric Investigation Plan

Albireo Pharma, Inc.  (ALBO) 
Last albireo pharma, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.albireopharma.com/investor-relations
PDF Agreement an essential step for a potential EU marketing authorization application              Completion of PIP would provide an additional two years of market exclusi [Read more]